Insider Trading activities of Salix Pharmaceuticals Ltd insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Salix Pharmaceuticals Ltd since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Salix Pharmaceuticals Ltd since year 2005. Table 2 shows the detailed insider transactions of Salix Pharmaceuticals Ltd since 2005. The reporting company's ticker symbol is SLXP. The reporting company's CIK number is 1009356.
The total value of stock buying since 2005 is $8,597,082.
The total value of stock sales since 2005 is $80,758,898.
The total value of stock option exercises since 2005 is $10,907,198.


Go to page:  1   2 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Salix Pharmaceuticals Ltd (SLXP).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2015-03 0 $0 71,480 $11,282,847 0 $0
2014-12 0 $0 0 $0 44,000 $775,720
2014-11 0 $0 11,079 $1,053,058 32,450 $571,220
2014-06 0 $0 53,057 $6,532,749 99,375 $1,875,206
2014-05 0 $0 900 $95,103 0 $0
2014-04 0 $0 11,530 $1,283,900 0 $0
2014-03 0 $0 11,319 $1,267,960 0 $0
2014-02 0 $0 0 $0 22,500 $424,642
2014-01 0 $0 81,014 $7,318,460 83,001 $1,555,665
2013-07 0 $0 12,000 $851,004 12,000 $210,360
2013-05 0 $0 2,008 $108,432 0 $0
2013-04 0 $0 44,859 $2,219,727 58,000 $799,300
2013-03 0 $0 10,000 $496,230 0 $0
2013-01 0 $0 3,000 $138,570 15,000 $114,000
2012-12 0 $0 88,000 $3,670,665 123,750 $976,500
2012-11 0 $0 9,450 $388,119 0 $0
2012-06 0 $0 141,850 $7,376,056 265,001 $1,078,553
2012-05 0 $0 11,000 $566,960 10,000 $175,300
2012-04 0 $0 0 $0 20,000 $81,400
2012-03 0 $0 12,375 $634,492 0 $0
2012-02 0 $0 30,823 $1,542,284 45,823 $247,697
2012-01 0 $0 4,977 $231,889 4,977 $36,988
2011-12 0 $0 4,700 $208,821 15,000 $61,050
2011-09 0 $0 1,360 $40,188 0 $0
2011-08 690 $20,430 3,000 $91,970 0 $0
2011-07 0 $0 20,357 $811,432 0 $0
2011-05 0 $0 25,052 $1,006,722 20,000 $350,600
2011-03 0 $0 1,675 $54,270 37,500 $684,450
2010-12 500 $22,399 0 $0 0 $0
2010-11 0 $0 35,000 $1,453,762 10,000 $175,300
2010-10 260 $9,880 25,000 $978,924 0 $0
2010-09 0 $0 43,871 $1,796,583 0 $0
2010-08 0 $0 6,500 $253,545 0 $0
2010-07 0 $0 25,000 $1,013,449 0 $0
2010-06 0 $0 4,278 $155,030 0 $0
2010-05 0 $0 33,377 $1,343,850 40,000 $45,199
2010-04 0 $0 11,879 $471,652 10,000 $175,300
2010-03 0 $0 25,000 $762,425 0 $0
2010-02 0 $0 0 $0 35,000 $39,549
2010-01 400 $10,996 0 $0 0 $0
2009-12 0 $0 15,000 $357,350 45,000 $50,879
2009-11 0 $0 23,377 $502,253 20,000 $22,660
2009-10 0 $0 20,000 $437,850 20,000 $22,660
2009-09 0 $0 1,059,953 $14,094,695 34,000 $38,491
2009-08 950 $11,837 107,121 $1,378,233 21,000 $23,793
2009-07 0 $0 379,612 $4,891,808 22,000 $24,926
2009-06 0 $0 22,000 $221,968 22,000 $24,926
2009-05 1,000 $10,385 33,500 $329,981 30,500 $119,764
2008-12 933,450 $7,772,732 3,500 $29,774 0 $0
2008-05 32,000 $218,382 1,622 $11,616 0 $0
2007-11 7,000 $73,360 5,100 $57,732 0 $0
2007-07 0 $0 15,209 $187,221 30,000 $0
2006-11 5,100 $72,471 13,200 $180,092 12,000 $91,200
2006-05 29,400 $374,210 0 $0 0 $0
2006-03 0 $0 0 $0 30,000 $33,900
2005-11 0 $0 30,000 $577,197 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Salix Pharmaceuticals Ltd insiders (SLXP)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-03-09 Forbes William P (President, Medical R&D and CDO) Sale 42,880 157.84 6,768,179
2015-03-06 Scruggs Rick D (Executive Vice President) Sale 4,000 157.55 630,200
2015-03-06 Forbes William P (EVP Research&Devel & CDO) Sale 20,000 157.96 3,159,200
2015-03-06 Creech Timothy J (See Remarks) Sale 4,600 157.67 725,268
2014-12-22 Logan Carolyn J (President & CEO) Option Ex 44,000 17.63 775,720
2014-11-24 Chappell John F (Director) Option Ex 15,000 17.63 264,450
2014-11-12 Forbes William P (EVP Research&Devel & CDO) Sale 11,079 95.05 1,053,058
2014-11-12 Forbes William P (EVP Research&Devel & CDO) Option Ex 17,450 17.58 306,770
2014-06-26 Logan Carolyn J (President & CEO) Sale 53,057 123.13 6,532,749
2014-06-26 Logan Carolyn J (President & CEO) Option Ex 99,375 18.87 1,875,206
2014-05-16 Scruggs Rick D (Executive Vice President) Sale 900 105.67 95,103
2014-04-22 D Alonzo Thomas (Director) Sale 11,530 111.35 1,283,900
2014-03-04 Scruggs Rick D (Executive Vice President) Sale 1,319 110.66 145,960
2014-03-04 Chappell John F (Director) Sale 10,000 112.20 1,122,000
2014-02-06 Chappell John F (Director) Option Ex 22,500 18.87 424,642
2014-01-10 D Alonzo Thomas (Director) Sale 12,050 92.34 1,112,697
2014-01-10 D Alonzo Thomas (Director) Option Ex 22,500 18.87 424,575
2014-01-09 Derbyshire Adam C (EVP Finance/CFO) Sale 30,001 91.70 2,750,941
2014-01-09 Derbyshire Adam C (EVP Finance/CFO) Option Ex 30,001 18.87 566,208
2014-01-08 Forbes William P (EVP Research&Devel & CDO) Sale 8,000 90.06 720,480
2014-01-08 Forbes William P (EVP Research&Devel & CDO) Option Ex 8,000 17.53 140,240
2014-01-07 Scruggs Rick D (Executive Vice President) Sale 8,463 88.31 747,367
2014-01-07 Keane William P (Director) Sale 22,500 88.31 1,986,975
2014-01-07 Keane William P (Director) Option Ex 22,500 18.87 424,642
2013-07-24 Forbes William P (EVP Research&Devel & CDO) Sale 12,000 70.92 851,004
2013-07-24 Forbes William P (EVP Research&Devel & CDO) Option Ex 12,000 17.53 210,360
2013-05-03 Sirgo Mark A (Director) Sale 2,008 54.00 108,432
2013-04-15 Keane William P (Director) Sale 30,000 49.44 1,483,200
2013-04-15 Keane William P (Director) Option Ex 30,000 15.25 457,410
2013-04-10 Forbes William P (EVP Research&Devel & CDO) Sale 8,673 49.37 428,186
2013-04-10 Forbes William P (EVP Research&Devel & CDO) Option Ex 13,000 17.53 227,890
2013-04-08 D Alonzo Thomas (Director) Sale 6,186 49.84 308,341
2013-04-08 D Alonzo Thomas (Director) Option Ex 15,000 7.60 114,000
2013-03-20 Sirgo Mark A (Director) Sale 3,000 50.05 150,150
2013-03-07 Scruggs Rick D (Executive Vice President) Sale 2,000 49.69 99,380
2013-03-06 Scruggs Rick D (Executive Vice President) Sale 5,000 49.34 246,700
2013-01-11 Sirgo Mark A (Director) Sale 3,000 46.19 138,570
2013-01-03 Chappell John F (Director) Option Ex 15,000 7.60 114,000
2012-12-26 Derbyshire Adam C (EVP Finance/CFO) Sale 60,000 41.44 2,486,400
2012-12-26 Derbyshire Adam C (EVP Finance/CFO) Option Ex 90,000 8.00 720,000
2012-12-20 Logan Carolyn J (President & CEO) Sale 25,000 42.27 1,056,675
2012-12-20 Logan Carolyn J (President & CEO) Option Ex 33,750 7.60 256,500
2012-12-04 Chappell John F (Director) Sale 3,000 42.53 127,590
2012-11-21 Chappell John F (Director) Sale 3,000 41.62 124,859
2012-11-14 Chappell John F (Director) Sale 3,000 41.15 123,450
2012-11-13 Sirgo Mark A (Director) Sale 1,725 40.75 70,293
2012-11-12 Sirgo Mark A (Director) Sale 1,725 40.30 69,517
2012-06-28 Logan Carolyn J (President & CEO) Sale 119,300 52.07 6,211,831
2012-06-28 Logan Carolyn J (President & CEO) Option Ex 228,467 4.07 929,860
2012-06-14 Logan Carolyn J (President & CEO) Option Ex 36,534 4.07 148,693
2012-06-08 D Alonzo Thomas (Director) Sale 9,550 51.63 493,066
2012-06-05 Keane William P (Director) Sale 10,000 51.67 516,689
2012-06-01 Chappell John F (Director) Sale 3,000 51.49 154,470
2012-05-08 Forbes William P (EVP Research&Devel & CDO) Sale 10,000 51.80 518,050
2012-05-08 Forbes William P (EVP Research&Devel & CDO) Option Ex 10,000 17.53 175,300
2012-05-01 Reeth Mark D (Gen Counsel&VP Corp Compliance) Sale 1,000 48.91 48,910
2012-04-13 Logan Carolyn J (President & CEO) Option Ex 20,000 4.07 81,400
2012-03-16 Franco Richard A (Director) Sale 9,375 51.98 487,312
2012-03-07 Chappell John F (Director) Sale 3,000 49.06 147,180
2012-02-28 Derbyshire Adam C (EVP Finance/CFO) Sale 12,600 50.09 631,134
2012-02-28 Derbyshire Adam C (EVP Finance/CFO) Option Ex 12,600 4.07 51,244
2012-02-13 Forbes William P (EVP Research&Devel & CDO) Sale 4,297 50.00 214,850
2012-02-13 Forbes William P (EVP Research&Devel & CDO) Option Ex 4,297 17.53 75,326
2012-02-13 Derbyshire Adam C (EVP Finance/CFO) Sale 12,891 50.00 644,550
2012-02-13 Derbyshire Adam C (EVP Finance/CFO) Option Ex 12,891 4.07 52,427
2012-02-03 Forbes William P (EVP Research&Devel & CDO) Sale 259 50.00 12,950
2012-02-03 Forbes William P (EVP Research&Devel & CDO) Option Ex 259 17.53 4,540
2012-02-03 Derbyshire Adam C (EVP Finance/CFO) Sale 776 50.00 38,800
2012-02-03 Derbyshire Adam C (EVP Finance/CFO) Option Ex 776 4.07 3,155
2012-02-02 Chappell John F (Director) Option Ex 15,000 4.07 61,005
2012-01-18 Forbes William P (EVP Research&Devel & CDO) Sale 125 50.00 6,250
2012-01-18 Forbes William P (EVP Research&Devel & CDO) Option Ex 125 17.53 2,191
2012-01-18 Derbyshire Adam C (EVP Finance/CFO) Sale 375 4.07 1,525
2012-01-18 Derbyshire Adam C (EVP Finance/CFO) Option Ex 375 4.07 1,525
2012-01-17 Forbes William P (EVP Research&Devel & CDO) Sale 1,119 50.06 56,016
2012-01-17 Forbes William P (EVP Research&Devel & CDO) Option Ex 1,119 17.53 19,616
2012-01-17 Derbyshire Adam C (EVP Finance/CFO) Sale 3,358 50.06 168,098
2012-01-17 Derbyshire Adam C (EVP Finance/CFO) Option Ex 3,358 4.07 13,656
2011-12-06 D Alonzo Thomas (Director) Sale 4,700 44.43 208,821
2011-12-06 D Alonzo Thomas (Director) Option Ex 15,000 4.07 61,050
2011-09-07 Chappell John F (Director) Sale 1,360 29.55 40,188
2011-08-31 Chappell John F (Director) Sale 2,000 31.14 62,280
2011-08-29 Chappell John F (Director) Sale 1,000 29.69 29,690
2011-08-11 D Alonzo Thomas (Director) Buy 690 29.61 20,430
2011-07-07 Forbes William P (EVP Research&Devel & CDO) Sale 13,000 39.60 514,761
2011-07-05 Reeth Mark D (Gen Counsel&VP Corp Compliance) Sale 7,357 40.32 296,671
2011-05-27 Sirgo Mark A (Director) Sale 1,675 38.93 65,207
2011-05-16 Reeth Mark D (Gen Counsel&VP Corp Compliance) Sale 3,377 39.84 134,536
2011-05-16 Forbes William P (EVP Research&Devel & CDO) Sale 20,000 40.35 806,979
2011-05-16 Forbes William P (EVP Research&Devel & CDO) Option Ex 20,000 17.53 350,600
2011-03-10 Sirgo Mark A (Director) Sale 1,675 32.40 54,270
2011-03-04 Franco Richard A (Director) Option Ex 37,500 18.25 684,450
2010-12-01 D Alonzo Thomas (Director) Buy 500 44.80 22,399
2010-11-22 Franco Richard A (Director) Sale 2,500 43.80 109,500
2010-11-12 Chappell John F (Director) Sale 22,500 41.96 944,212
2010-11-10 Forbes William P (V.P. Research& Devel & CDO) Sale 10,000 40.00 400,050
2010-11-10 Forbes William P (V.P. Research& Devel & CDO) Option Ex 10,000 17.53 175,300
2010-10-20 Chappell John F (Director) Sale 25,000 39.16 978,924
2010-10-07 D Alonzo Thomas (Director) Buy 260 38.00 9,880
2010-09-21 Logan Carolyn J (President & CEO) Sale 14,000 42.35 592,858
2010-09-15 Forbes William P (V.P. Research& Devel & CDO) Sale 10,695 40.50 433,104
2010-09-09 Chappell John F (Director) Sale 4,676 40.92 191,341
2010-09-07 Chappell John F (Director) Sale 4,000 40.42 161,680
2010-09-03 Franco Richard A (Director) Sale 6,500 40.00 260,000
2010-09-02 Chappell John F (Director) Sale 4,000 39.40 157,600
2010-08-26 Franco Richard A (Director) Sale 6,500 39.01 253,545
2010-07-12 Chappell John F (Director) Sale 25,000 40.54 1,013,449
2010-06-14 Reeth Mark D (Gen Counsel&VP Corp Compliance) Sale 4,278 36.24 155,030
2010-05-17 Reeth Mark D (Gen Counsel&VP Corp Compliance) Sale 3,377 37.38 126,225
2010-05-10 Logan Carolyn J (President & CEO) Option Ex 40,000 1.13 45,199
2010-05-03 Franco Richard A (Director) Sale 5,000 40.22 201,100
2010-05-03 Chappell John F (Director) Sale 25,000 40.66 1,016,525
2010-04-14 Forbes William P (V.P. Research& Devel & CDO) Sale 10,000 40.02 400,250
2010-04-14 Forbes William P (V.P. Research& Devel & CDO) Option Ex 10,000 17.53 175,300
2010-04-01 Forbes William P (V.P. Research& Devel & CDO) Sale 1,879 38.00 71,402
2010-03-16 Chappell John F (Director) Sale 25,000 30.50 762,425
2010-02-19 Logan Carolyn J (President & CEO) Option Ex 35,000 1.13 39,549
2010-01-15 Sirgo Mark A (Director) Buy 200 27.09 5,418
2010-01-06 Sirgo Mark A (Director) Buy 200 27.89 5,578
2009-12-23 Forbes William P (V.P. Research& Devel & CDO) Sale 5,000 25.00 125,000
2009-12-10 Logan Carolyn J (President & CEO) Option Ex 35,000 1.13 39,549
2009-12-09 Derbyshire Adam C (EVP Finance/CFO) Sale 5,000 23.10 115,500
2009-12-09 Derbyshire Adam C (EVP Finance/CFO) Option Ex 5,000 1.13 5,665
2009-12-02 Derbyshire Adam C (EVP Finance/CFO) Sale 5,000 23.37 116,850
2009-12-02 Derbyshire Adam C (EVP Finance/CFO) Option Ex 5,000 1.13 5,665
2009-11-25 Derbyshire Adam C (EVP Finance/CFO) Sale 5,000 23.58 117,899
2009-11-25 Derbyshire Adam C (EVP Finance/CFO) Option Ex 5,000 1.13 5,665
2009-11-23 Reeth Mark D (Gen Counsel&VP Corp Compliance) Sale 3,377 23.64 79,849
2009-11-18 Derbyshire Adam C (EVP Finance/CFO) Sale 5,000 21.05 105,250
2009-11-18 Derbyshire Adam C (EVP Finance/CFO) Option Ex 5,000 1.13 5,665
2009-11-11 Derbyshire Adam C (EVP Finance/CFO) Sale 5,000 20.12 100,600
2009-11-11 Derbyshire Adam C (EVP Finance/CFO) Option Ex 5,000 1.13 5,665
2009-11-04 Derbyshire Adam C (EVP Finance/CFO) Sale 5,000 19.73 98,655
2009-11-04 Derbyshire Adam C (EVP Finance/CFO) Option Ex 5,000 1.13 5,665
2009-10-28 Derbyshire Adam C (EVP Finance/CFO) Sale 5,000 19.79 98,950
2009-10-28 Derbyshire Adam C (EVP Finance/CFO) Option Ex 5,000 1.13 5,665
2009-10-21 Derbyshire Adam C (EVP Finance/CFO) Sale 5,000 21.00 105,000
2009-10-21 Derbyshire Adam C (EVP Finance/CFO) Option Ex 5,000 1.13 5,665
2009-10-14 Derbyshire Adam C (EVP Finance/CFO) Sale 5,000 22.89 114,450
2009-10-14 Derbyshire Adam C (EVP Finance/CFO) Option Ex 5,000 1.13 5,665
2009-10-07 Derbyshire Adam C (EVP Finance/CFO) Sale 5,000 23.89 119,450
2009-10-07 Derbyshire Adam C (EVP Finance/CFO) Option Ex 5,000 1.13 5,665
2009-09-30 Derbyshire Adam C (EVP Finance/CFO) Sale 5,000 21.04 105,200
2009-09-30 Derbyshire Adam C (EVP Finance/CFO) Option Ex 5,000 1.13 5,665
2009-09-23 Derbyshire Adam C (EVP Finance/CFO) Sale 5,000 20.73 103,650
2009-09-23 Derbyshire Adam C (EVP Finance/CFO) Option Ex 5,000 1.13 5,665
2009-09-16 Derbyshire Adam C (EVP Finance/CFO) Sale 5,000 19.80 99,000
2009-09-16 Derbyshire Adam C (EVP Finance/CFO) Option Ex 5,000 1.13 5,665
2009-09-14 Logan Carolyn J (President & CEO) Sale 10,000 20.67 206,740
2009-09-14 Logan Carolyn J (President & CEO) Option Ex 10,000 1.13 11,299
Go to page:  1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of SLXP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Salix Pharmaceuticals Ltd (symbol SLXP, CIK number 1009356) see the Securities and Exchange Commission (SEC) website.